Accéder au contenu
Merck

The role of excitatory amino acids and NMDA receptors in traumatic brain injury.

Science (New York, N.Y.) (1989-05-19)
A I Faden, P Demediuk, S S Panter, R Vink
RÉSUMÉ

Brain injury induced by fluid percussion in rats caused a marked elevation in extracellular glutamate and aspartate adjacent to the trauma site. This increase in excitatory amino acids was related to the severity of the injury and was associated with a reduction in cellular bioenergetic state and intracellular free magnesium. Treatment with the noncompetitive N-methyl-D-aspartate (NMDA) antagonist dextrophan or the competitive antagonist 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid limited the resultant neurological dysfunction; dextrorphan treatment also improved the bioenergetic state after trauma and increased the intracellular free magnesium. Thus, excitatory amino acids contribute to delayed tissue damage after brain trauma; NMDA antagonists may be of benefit in treating acute head injury.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Dextrorphan tartrate, powder